| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 08/27/2009 | WO2009105214A2 Selective androgen receptor modulators |
| 08/27/2009 | WO2009103626A1 4, 5-dihydro-oxazol-2-yl amine derivatives |
| 08/27/2009 | US20090216017 Process for producing biaryl compound |
| 08/27/2009 | US20090211038 Hemicyanin styryl thiol/disulfide dye, composition comprising hemicyanin styryl thiol/disulfide dye, and method for lightening keratin materials using hemicyanin styryl thiol/disulfide dye |
| 08/27/2009 | CA2716320A1 Selective androgen receptor modulators |
| 08/27/2009 | CA2712228A1 4,5-dihydro-oxazol-2-yl amine derivatives |
| 08/26/2009 | EP2093220A2 Inhibitors of fatty acid amide hydrolase |
| 08/26/2009 | EP2091927A1 Thiazole and oxazole-substituted arylamides |
| 08/26/2009 | EP2091915A1 Novel diphenylazetidinone substituted by piperazine-1-sulfonic acid having improved pharmacological properties |
| 08/26/2009 | EP1756071B1 Benzoxazolone derivatives, processes for preparing them and their uses |
| 08/26/2009 | CN101516861A Method for producing bisbenzoxazoles |
| 08/26/2009 | CN101516860A Benzoxazoles and oxazolopyridines being useful as FANUS kinases inhibitors |
| 08/26/2009 | CN101516856A Heterocyclic bridged biphenyls and their use in oleds |
| 08/26/2009 | CN101514190A Method for preparing heterocyclic compounds of methyl mercapto under ionic liquid catalysis |
| 08/26/2009 | CN100532368C Preparation method of 2-(4-hydroxy benzoxy) 6-chlorobenzene diozaiole |
| 08/25/2009 | US7579479 Modulators of blood glucose levels, triglyceride levels, insulin levels and non-esterified fatty acid (NEFA) levels; hypoglycemia |
| 08/25/2009 | US7579478 Process for the purification of substituted benzoxazole compounds |
| 08/25/2009 | US7579465 For treatment of picornavirus infections in mammals |
| 08/25/2009 | US7579347 Vanilloid receptor ligands and their use in treatments |
| 08/25/2009 | CA2366932C Cyclic protein tyrosine kinase inhibitors |
| 08/20/2009 | WO2009101082A1 Substituted sulfonic acid amide compounds |
| 08/20/2009 | WO2009043889A3 Oxadiazole derivatives |
| 08/20/2009 | US20090209602 Chemical compounds |
| 08/20/2009 | US20090209596 Oxazole Hydroxamic Acid Derivatives and Use Thereof |
| 08/20/2009 | US20090209529 4,5-dihydro-oxazol-2-yl amine derivatives |
| 08/20/2009 | US20090209511 Benzofuran Derivatives |
| 08/19/2009 | EP1846379B1 Antidiabetic bicyclic compounds |
| 08/19/2009 | EP1641453B1 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent |
| 08/19/2009 | EP1635824B1 5-membered heterocycle-based p-38 inhibitors |
| 08/19/2009 | CN101511802A Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators |
| 08/19/2009 | CN101508682A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 08/19/2009 | CN100529963C Photosensitive composition and new compound therefor |
| 08/19/2009 | CN100528851C Process for the recovery of oxazole |
| 08/19/2009 | CN100528850C Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 08/18/2009 | US7576200 Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 08/18/2009 | US7576198 A hydroxy compound containing substituted orpyridine, pyrazine, pyrimidine, oxazole, thiadiazole, quinoline, isoquinoline etc. as anti HIV agent, for treating AIDS |
| 08/18/2009 | US7576108 Substituted arylcyclopropylacetamides as glucokinase activators |
| 08/13/2009 | WO2009098455A1 2- (9h-xanthen-9-yl) -oxazol derivatives as m3 muscarinic receptor antagonists for the treatment of asthma and chronic obstructive lung disease |
| 08/13/2009 | WO2008042497A3 Benzoxazole and benzothiazole compounds useful as authentication compounds in polymer articles |
| 08/13/2009 | US20090204336 PDZ-Domain Modulators |
| 08/13/2009 | US20090203906 4-[((4-carboxybutyl){2-[2-({4-[2-(4-hydroxyphenyl)ethyl]benzyl}oxy)phenyl]-ethyl}amino)methyl]benzoic acid, which stimulate soluble guanylate cyclase via a novel mechanism of action, used for the treatment of cardiovascular disorders and fibrotic disorders |
| 08/13/2009 | US20090203904 Arylsulfinate salts in photoinitiator systems for polymerization reactions |
| 08/13/2009 | US20090203712 Urea Derivative |
| 08/13/2009 | US20090202921 Optical recording composition and holographic recording medium |
| 08/13/2009 | US20090202920 Optical recording composition and holographic recording medium |
| 08/12/2009 | EP1592676B1 Process for the recovery of oxazole |
| 08/12/2009 | CN101506181A Tricyclic compound and pharmaceutical use thereof |
| 08/12/2009 | CN101506180A Human protein tyrosine phosphatase inhibitors and methods of use |
| 08/12/2009 | CN101506161A Positively charged water-soluble prodrugs of aryl- and heteroarylpropionic acids with very fast skin penetration rate |
| 08/12/2009 | CN101506140A Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 08/12/2009 | CN101504341A Preparation for eel muscle freeze-dried powder substrate standard substance containing furazolidone metabolite 3-amino-2-oxazolone(AOZ) |
| 08/12/2009 | CN100526303C preparation process of safe herbicide preparation of N-dichloroacetyl oxazolidine herbicide |
| 08/06/2009 | WO2008103354A3 Modulators of acetyl-coenzyme a carboxylase and methods of use thereof |
| 08/06/2009 | US20090198070 Condensation Reaction by Metal Catalyst |
| 08/06/2009 | US20090197863 Benzoxazole carboxamide inhibitors of poly(adp-ribose)polymerase (parp) |
| 08/06/2009 | US20090197795 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 08/05/2009 | EP2084139A2 Oxazolidinium compounds and use as hydrate inhibitors |
| 08/05/2009 | CN101501031A Oxazolidone derivatives as pr modulators |
| 08/05/2009 | CN100522971C Method for synthesizing oxazole pyridone compound |
| 08/05/2009 | CN100522171C 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 08/04/2009 | US7569601 Such as (2E)-3-{4-[1-ethyl-2,2-bis(4-hydroxyphenyl)ethenyl]phenyl}-2-propenoic acid; for selective estrogen receptor modulation; menopausal or postmenopausal disorders, vasomotor symptoms, urogenital or vulvar vaginal atrophy, atrophic vaginitis, female sexual dysfunction, breast cancer, osteoporosis |
| 08/04/2009 | US7569594 antiproliferative agents; cancer |
| 08/04/2009 | CA2221110C Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension |
| 07/30/2009 | WO2009092324A1 Oxazolidine derivatives as nmda antagonists |
| 07/30/2009 | US20090192317 Process for the synthesis of 2-aminoxazole compounds |
| 07/30/2009 | US20090192206 Mercaptoimidazoles as ccr2 receptor antagonists |
| 07/30/2009 | US20090192203 Compounds and compositions as ppar modulators |
| 07/30/2009 | US20090192197 Antibiotics with improved solubility, lower toxicity; potent antibacterial activity; includes Torezolid phosphate |
| 07/30/2009 | US20090192122 Inflammatory cytokine release inhibitor |
| 07/29/2009 | EP2081913A2 Benzimidazole,benzoxazole and benzothiazole derivatives, optical film comprising them and method of production thereof |
| 07/29/2009 | EP2081912A1 Heterocyclic bridged biphenyls and their use in oleds |
| 07/29/2009 | EP2081905A2 Sulfonyl compounds which modulate the cb2 receptor |
| 07/29/2009 | EP1807407B1 Aromatic amides as inhibitors of c-fms kinase |
| 07/29/2009 | EP1682127B1 Thiazoles and oxazoles useful as modulators of atp-binding cassette transporters |
| 07/29/2009 | EP1601671B1 Cycloalkyl derivatives comprising bioisosteric carboxylic acid groups, method for the production thereof, and use thereof as a medicament |
| 07/28/2009 | US7566730 Substituted aminoethers for the treatment of Alzheimer's disease |
| 07/23/2009 | WO2009090177A1 Bifeprunox derivatives |
| 07/23/2009 | WO2009067663A8 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds |
| 07/23/2009 | US20090187031 compounds which mimic the chemical and biological activity of discodermolide; may have use as anticancer agent |
| 07/23/2009 | US20090186905 Anaplastic lymphoma kinase modulators and methods of use |
| 07/23/2009 | US20090186834 Diphenylheterocycle cholesterol absorption inhibitors |
| 07/23/2009 | US20090186790 Photo-labile pro-fragrance conjugates |
| 07/23/2009 | US20090184235 Merocyanine dye and photoelectric conversion device |
| 07/23/2009 | CA2711520A1 Bifeprunox derivatives |
| 07/22/2009 | EP2079716A1 Method for producing bisbenzoxazoles |
| 07/22/2009 | CN101490022A Benzoxazole and benzothiazole derivatives as 5-hydroxytrytamine-6 ligands |
| 07/21/2009 | US7563904 (S)-4-{4-[N'-(2-Oxotetrahydropyran-3-iliden)hidrazino]benzyl}-1,3-oxazolidin-2-one; industrial scale production, purity, free of using toxic reagent |
| 07/21/2009 | US7563877 Macrolide antibiotics; active against Macrolides-Lincosamides-type B Streptogramines; reduction, chlorination, |
| 07/16/2009 | US20090182023 Tricyclic compound and pharmaceutical use thereof |
| 07/16/2009 | US20090181962 Substituted thiophene compounds |
| 07/15/2009 | EP1745048A4 Simple stereocontrolled synthesis of salinosporamide a |
| 07/15/2009 | EP1379514B1 5-membered heterocycles, preparation and application thereof as medicaments |
| 07/15/2009 | CN101481359A Cyclic protein tyrosine kinase inhibitors |
| 07/14/2009 | US7560589 Cycloalkylidene compounds as modulators of estrogen receptor |
| 07/14/2009 | US7560570 Inhibitors of fatty acid amide hydrolase |
| 07/14/2009 | US7560569 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity |
| 07/14/2009 | US7560561 Such as terfenadine carboxylic acid metabolite and carebastine using a 4-(4-halo-1-oxobutyl)-alpha,alpha-dimethyl-alpha-substituted toluene intermediate |
| 07/14/2009 | US7560488 orally administering 250 mg of 2',4'-difluoro-4-hydroxy-[1,1'-biphenyl]-3-carboxylic acid (Diflunisal) twice per day; for neuropathic pain, cardiomyopathy, amyloidosis, following liver transplantation |
| 07/14/2009 | US7560483 Synthesizing 1- (acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amenable |
| 07/14/2009 | US7560475 3-(2-{5-methyl-2-[4-(trifluoromethyl)piperidin-1-yl]-1,3-thiazol-4-yl}ethoxy)phenyl]acetic acid,peroxime proliferator-activated receptor antagonists; side effect reduction; very low toxicity, especially hepatotoxicity; metabolic disorders; antidiabetic agents; anticholesterol agents; antilipemic agents |